Baseline Body Surface Area and Itch Severity Define Response to Baricitinib in Patients with Moderate-to-Severe Atopic Dermatitis at Week 16

被引：0
|
作者：
Jacob P. Thyssen
Marjolein de Bruin-Weller
Antonio Costanzo
Susanne Grond
Christopher Schuster
Chunyuan Liu
Maria Jose Rueda
Yun-Fei Chen
Andreas Pinter
Thomas Bieber
机构：
[1] University of Copenhagen,Department of Dermatology, Bispebjerg Hospital
[2] University Medical Center Utrecht,Department of Dermatology and Allergology, National Expertise Center of Atopic Dermatitis
[3] Humanitas University,Dermatology, Department of Biomedical Sciences
[4] Humanitas Research Hospital,Dermatology
[5] Eli Lilly and Company,Department of Dermatology
[6] Medical University of Vienna,Department of Dermatology, Venereology and Allergology
[7] Tigermed-BDM Inc,Department of Dermatology and Allergy
[8] University Hospital Frankfurt,undefined
[9] University Hospital,undefined
[10] Christine Kühne-Center for Allergy Research and Education (CK-CARE),undefined
来源：
Advances in Therapy | 2023年 / 40卷
关键词：
Atopic dermatitis; Classification and regression tree analysis; Severe itch;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3574 / 3587
页数：13
相关论文
共 50 条
  • [11] Dupilumab Treatment Rapidly Improves Itch in Patients With Moderate-to-Severe Atopic Dermatitis
    Silverberg, Jonathan I.
    Chao, Jingdong
    Eckert, Laurent
    Chen, Zhen
    Ardeleanu, Marius
    Shumel, Brad
    Plaum, Stefan
    Graham, Neil M. H.
    Pirozzi, Gianluca
    Gadkari, Abhijit
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 : 29 - 29
  • [12] DUPILUMAB TREATMENT RAPIDLY IMPROVES ITCH IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
    Silverberg, J.
    Chao, J.
    Eckert, L.
    Chen, Z.
    Ardeleanu, M.
    Shumel, B.
    Plaum, S.
    Graham, N.
    Pirozzi, G.
    Gadkari, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S95 - S95
  • [13] EFFICACY OF BARICITINIB STRATIFIED BY BASELINE BODY SURFACE AREA IN ADULTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: A POST HOC ANALYSIS FROM BREEZE-AD1/2
    Thyssen, Jacob P.
    Costanzo, Antonio
    Grond, Susanne
    Lu, Na
    Liu, Chunyuan
    Wollenberg, Andreas
    ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 35 - 35
  • [14] Early improvements in signs and symptoms predict clinical response to baricitinib in patients with moderate-to-severe atopic dermatitis
    Bieber, Thomas
    Thyssen, Jacob P.
    Irvine, Alan D.
    Tsunemi, Yuichiro
    Chen, Yun-Fei
    Sun, Luna
    Schloebe, Andrea
    Riedl, Elisabeth
    Cork, Michael J.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2023, 48 (08) : 881 - 888
  • [15] Prolonged real-life experience with baricitinib in patients with moderate-to-severe atopic dermatitis
    De Greef, Axel
    Ghislain, Pierre-Dominique
    Baeck, Marie
    EUROPEAN JOURNAL OF DERMATOLOGY, 2023, 33 (06) : 707 - 709
  • [16] Evaluating the safety and efficacy of baricitinib for the treatment of moderate-to-severe atopic dermatitis
    Bridgeman, Sarah G.
    Martino, Anna K.
    Strowd, Lindsay C.
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (18) : 2153 - 2159
  • [17] Selected infection topics in adult patients with moderate-to-severe atopic dermatitis treated with baricitinib
    Gooderham, Melinda
    Weisman, Jamie
    Goldblum, Orin
    Brinker, Dennis
    Issa, Maher
    Reich, Kristian
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB77 - AB77
  • [18] Aggregate Response Benefit in Skin Clearance and Itch Reduction With Upadacitinib or Dupilumab in Patients With Moderate-to-Severe Atopic Dermatitis
    Silverberg, Jonathan I.
    de Bruin-Weller, Marjolein
    Calimlim, Brian M.
    Hu, Xiaofei
    Ofori, Sarah A.
    Platt, Andrew M.
    Teixeira, Henrique D.
    Eyerich, Kilian
    Thyssen, Jacob P.
    DERMATITIS, 2024, 35 (03) : 266 - 274
  • [19] SHORT-TERM EFFICACY AND SAFETY OF ABROCITINIB BY BASELINE DISEASE SEVERITY IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
    Rice, Zakiya P.
    Gooderham, Melinda J.
    Lebwohl, Mark G.
    Simpson, Eric L.
    Boguniewicz, Mark
    Wollenberg, Andreas
    Lazariciu, Irina
    Chan, Gary L.
    Alderfer, Justine
    Watkins, Melissa
    ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 30 - 30
  • [20] Ocular surface disease is common in moderate-to-severe atopic dermatitis patients
    Achten, Roselie E.
    Bakker, Daphne S.
    van Luijk, Chantal M.
    van Der Wal, Marlot
    de Graaf, Marlies
    van Wijk, Femke
    Zuithoff, Nicolaas P. A.
    van Der Rijst, Lisa P.
    Boesjes, Celeste M.
    Thijs, Judith L.
    de Boer, Joke H.
    de Bruin-Weller, Marjolein S.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2022, 52 (06): : 801 - 805
12345